Retrolaminar Plane Block Versus Anterior Quadratus Lumborum Block in Pediatric Urogenital Surgery
Comparison of the Postoperative Analgesic Efficacy of Retrolaminar Plane Block and Anterior Quadratus Lumborum Block in Pediatric Lower Urogenital Surgery: A Randomized Controlled Trial
1 other identifier
interventional
76
1 country
1
Brief Summary
Effective control of postoperative pain following pediatric lower urogenital surgery is important for enhancing recovery and reducing opioid requirements. Anterior quadratus lumborum block and retrolaminar block are two ultrasound-guided truncal block techniques used for perioperative analgesia in lower abdominal surgery. However, direct comparisons of their analgesic efficacy in pediatric lower urogenital procedures remain limited. This prospective, randomized, controlled trial will enroll 76 pediatric patients aged 6 months to 12 years with American Society of Anesthesiologists physical status I-III who are scheduled for elective lower urogenital surgery. Participants will be randomly assigned in a 1:1 ratio to receive either an anterior quadratus lumborum block or a retrolaminar block. Both techniques will be performed under ultrasound guidance in addition to standardized general anesthesia. The primary outcome will be rescue analgesic requirement during the first 24 postoperative hours. Secondary outcomes will include postoperative pain scores, time to first rescue analgesic administration, intraoperative remifentanil consumption, adverse effects such as nausea and vomiting, and caregiver satisfaction. The study aims to compare the postoperative analgesic efficacy and safety of anterior quadratus lumborum block and retrolaminar block in pediatric patients undergoing lower urogenital surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jul 2026
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 14, 2026
CompletedFirst Posted
Study publicly available on registry
July 17, 2026
CompletedStudy Start
First participant enrolled
July 25, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 20, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
September 1, 2027
July 17, 2026
July 1, 2026
12 months
July 14, 2026
July 14, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Total Rescue Analgesic Requirement During the First 24 Postoperative Hours
Total rescue analgesic consumption during the first 24 postoperative hours will be recorded. Pain assessment will be performed using the Face, Legs, Activity, Cry, and Consolability Scale. The scale ranges from 0 to 10, with higher scores indicating greater pain intensity. Rescue analgesia will be administered when the score is 4 or higher.
First 24 hours after surgery
Secondary Outcomes (3)
Postoperative Pain Scores
Postoperative 1, 2, 4, 8, 16, and 24 hours
Time to First Rescue Analgesic Administration
First 24 hours after surgery
Intraoperative Remifentanil Consumption
From induction of anesthesia until the end of surgery
Study Arms (2)
Anterior Quadratus Lumborum Block Group
EXPERIMENTALParticipants assigned to this group will receive an ultrasound-guided anterior quadratus lumborum block following induction of general anesthesia for postoperative analgesia. The block will be performed under sterile conditions using 0.25 percent bupivacaine at a volume of 0.4 milliliters per kilogram. Standardized general anesthesia and postoperative analgesic protocols will be applied to all participants.
Retrolaminar Block Group
EXPERIMENTALParticipants assigned to this group will receive an ultrasound-guided retrolaminar block following induction of general anesthesia for postoperative analgesia. The block will be performed under sterile conditions using 0.25 percent bupivacaine at a volume of 0.4 milliliters per kilogram. Standardized general anesthesia and postoperative analgesic protocols will be applied to all participants.
Interventions
An ultrasound-guided retrolaminar block will be performed after induction of general anesthesia. After identification of the target vertebral lamina, 0.25 percent bupivacaine will be administered into the retrolaminar plane at a volume of 0.4 milliliters per kilogram.
An ultrasound-guided anterior quadratus lumborum block will be performed after induction of general anesthesia. Following identification of the quadratus lumborum and psoas major muscles, 0.25 percent bupivacaine will be injected into the fascial plane between these muscles at a volume of 0.4 milliliters per kilogram.
Eligibility Criteria
You may qualify if:
- Age between 6 months and 12 years
- Scheduled for lower abdominal urogenital surgery (e.g., inguinal hernia repair or orchiopexy for undescended testis)
- American Society of Anesthesiologists physical status classification I-III
- Written informed consent obtained from a parent or legal guardian
You may not qualify if:
- History of allergy to local anesthetic agents
- Presence of infection at the planned injection site
- Coagulopathy or any other condition contraindicating regional anesthesia
- Planned laparoscopic orchiopexy
- American Society of Anesthesiologists physical status classification IV
- Inability to obtain informed consent from a parent or legal guardian
- Anticipated requirement for postoperative intensive care unit admission
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Istanbul University-Cerrahpasa, Cerrahpasa Medicine of Faculty
Bakırköy, Istanbul, 34153, Turkey (Türkiye)
Study Officials
- PRINCIPAL INVESTIGATOR
münevver kayhan
Istanbul University-Cerrahpasa, Cerrahpasa Medicine of Faculty
- STUDY DIRECTOR
Ayse Cigdem Tutuncu, Professor Doctor
Istanbul University-Cerrahpasa, Cerrahpasa Medicine of Faculty
- STUDY CHAIR
Pinar Kendigelen, Professor Doctor
Istanbul University-Cerrahpasa, Cerrahpasa Medicine of Faculty
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- The anesthesiologist responsible for evaluating eligibility criteria, monitoring intraoperative and postoperative pain scores and analgesic consumption, collecting study data, and performing statistical analyses will be blinded to group allocation. Participants and their caregivers will also remain blinded throughout the study. Randomization will be conducted by an independent investigator who will not be involved in patient recruitment, block performance, perioperative management, outcome assessment, or data analysis. Due to the nature of the interventions, the anesthesiologist performing the regional block procedures will be aware of group allocation and cannot be blinded. This anesthesiologist will not participate in postoperative assessments, data collection, or statistical analyses. Postoperative pain assessments on the ward will be performed every 4 hours by blinded nursing staff using the Face, Legs, Activity, Cry, and Consolability Scale. Patients with a score of 4 or greater w
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Lecturer
Study Record Dates
First Submitted
July 14, 2026
First Posted
July 17, 2026
Study Start
July 25, 2026
Primary Completion (Estimated)
July 20, 2027
Study Completion (Estimated)
September 1, 2027
Last Updated
July 17, 2026
Record last verified: 2026-07
Data Sharing
- IPD Sharing
- Will not share